Drug and Therapeutics Bulletin 2002;40:38-40; doi:10.1136/dtb.2002.40538
Copyright © 2002 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

MS, Parkinson's disease and physiotherapy

In the UK, around 10-12 in every 10,000 people have multiple sclerosis,^1,2 typical features of which include weakness, ataxia, spasticity and sensory loss. By comparison, around 16-18 in every 10,000 have Parkinson's disease, a condition typified by rigidity, bradykinesia, tremor and postural instability. Both conditions can limit function with, for example, nearly 25% of patients with multiple sclerosis and about 10% of those with Parkinson's disease being dependent on a wheelchair.^2,3 Physiotherapy is widely used as part of a multidisciplinary approach to the management of multiple sclerosis, while 7-38% of people with Parkinson's disease are referred for physiotherapy.⁴ Here, we review the evidence for physiotherapy in the management of patients with either condition.